These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 9045618)
41. Pam and its ortholog highwire interact with and may negatively regulate the TSC1.TSC2 complex. Murthy V; Han S; Beauchamp RL; Smith N; Haddad LA; Ito N; Ramesh V J Biol Chem; 2004 Jan; 279(2):1351-8. PubMed ID: 14559897 [TBL] [Abstract][Full Text] [Related]
42. Tuberous sclerosis gene products in proliferation control. Hengstschläger M; Rodman DM; Miloloza A; Hengstschläger-Ottnad E; Rosner M; Kubista M Mutat Res; 2001 Jul; 488(3):233-9. PubMed ID: 11397651 [TBL] [Abstract][Full Text] [Related]
43. The tumor suppressor tuberin regulates mitotic onset through the cellular localization of cyclin B1. Fidalgo da Silva E; Ansari SB; Maimaiti J; Barnes EA; Kong-Beltran M; Donoghue DJ; Porter LA Cell Cycle; 2011 Sep; 10(18):3129-39. PubMed ID: 21900748 [TBL] [Abstract][Full Text] [Related]
44. A role of the tuberous sclerosis gene-2 product during neuronal differentiation. Soucek T; Hölzl G; Bernaschek G; Hengstschläger M Oncogene; 1998 Apr; 16(17):2197-204. PubMed ID: 9619828 [TBL] [Abstract][Full Text] [Related]
45. Rhebbing up mTOR: new insights on TSC1 and TSC2, and the pathogenesis of tuberous sclerosis. Kwiatkowski DJ Cancer Biol Ther; 2003; 2(5):471-6. PubMed ID: 14614311 [TBL] [Abstract][Full Text] [Related]
46. The p38 and MK2 kinase cascade phosphorylates tuberin, the tuberous sclerosis 2 gene product, and enhances its interaction with 14-3-3. Li Y; Inoki K; Vacratsis P; Guan KL J Biol Chem; 2003 Apr; 278(16):13663-71. PubMed ID: 12582162 [TBL] [Abstract][Full Text] [Related]
47. Tuberous sclerosis as an underlying basis for infantile spasm. Yeung RS Int Rev Neurobiol; 2002; 49():315-32. PubMed ID: 12040899 [TBL] [Abstract][Full Text] [Related]
48. Tuberous sclerosis: immunohistochemistry expression of tuberin and hamartin in a 31-week gestational fetus. Vinaitheerthan M; Wei J; Mizuguchi M; Greco A; Barness EG Fetal Pediatr Pathol; 2004; 23(4):241-9. PubMed ID: 16095035 [TBL] [Abstract][Full Text] [Related]
49. Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. Dan HC; Sun M; Yang L; Feldman RI; Sui XM; Ou CC; Nellist M; Yeung RS; Halley DJ; Nicosia SV; Pledger WJ; Cheng JQ J Biol Chem; 2002 Sep; 277(38):35364-70. PubMed ID: 12167664 [TBL] [Abstract][Full Text] [Related]
50. Analysis of TSC2 stop codon variants found in tuberous sclerosis patients. Goedbloed MA; Nellist M; Verhaaf B; Reuser AJ; Lindhout D; Sunde L; Verhoef S; Halley DJ; van den Ouweland AM Eur J Hum Genet; 2001 Nov; 9(11):823-8. PubMed ID: 11781698 [TBL] [Abstract][Full Text] [Related]
51. Characterisation of a novel TSC2 missense mutation in the GAP related domain associated with minimal clinical manifestations of tuberous sclerosis. Mayer K; Goedbloed M; van Zijl K; Nellist M; Rott HD J Med Genet; 2004 May; 41(5):e64. PubMed ID: 15121792 [No Abstract] [Full Text] [Related]
52. Distinct Rab-binding domains mediate the interaction of Rabaptin-5 with GTP-bound Rab4 and Rab5. Vitale G; Rybin V; Christoforidis S; Thornqvist P; McCaffrey M; Stenmark H; Zerial M EMBO J; 1998 Apr; 17(7):1941-51. PubMed ID: 9524117 [TBL] [Abstract][Full Text] [Related]
53. A calmodulin binding site in the tuberous sclerosis 2 gene product is essential for regulation of transcription events and is altered by mutations linked to tuberous sclerosis and lymphangioleiomyomatosis. Noonan DJ; Lou D; Griffith N; Vanaman TC Arch Biochem Biophys; 2002 Feb; 398(1):132-40. PubMed ID: 11811958 [TBL] [Abstract][Full Text] [Related]
54. Hamartin and tuberin interaction with the G2/M cyclin-dependent kinase CDK1 and its regulatory cyclins A and B. Catania MG; Mischel PS; Vinters HV J Neuropathol Exp Neurol; 2001 Jul; 60(7):711-23. PubMed ID: 11444800 [TBL] [Abstract][Full Text] [Related]
55. Two distinct effectors of the small GTPase Rab5 cooperate in endocytic membrane fusion. Gournier H; Stenmark H; Rybin V; Lippé R; Zerial M EMBO J; 1998 Apr; 17(7):1930-40. PubMed ID: 9524116 [TBL] [Abstract][Full Text] [Related]
56. Tuberous sclerosis genes regulate cellular 14-3-3 protein levels. Hengstschläger M; Rosner M; Fountoulakis M; Lubec G Biochem Biophys Res Commun; 2003 Dec; 312(3):676-83. PubMed ID: 14680818 [TBL] [Abstract][Full Text] [Related]
57. TSC1 and TSC2: genes that are mutated in the human genetic disorder tuberous sclerosis. Sampson JR Biochem Soc Trans; 2003 Jun; 31(Pt 3):592-6. PubMed ID: 12773162 [TBL] [Abstract][Full Text] [Related]
58. Loss of tuberin from cerebral tissues with tuberous sclerosis and astrocytoma. Mizuguchi M; Kato M; Yamanouchi H; Ikeda K; Takashima S Ann Neurol; 1996 Dec; 40(6):941-4. PubMed ID: 9007104 [TBL] [Abstract][Full Text] [Related]
59. Tuberin immunohistochemistry in brain, kidneys and heart with or without tuberous sclerosis. Mizuguchi M; Kato M; Yamanouchi H; Ikeda K; Takashima S Acta Neuropathol; 1997 Dec; 94(6):525-31. PubMed ID: 9444353 [TBL] [Abstract][Full Text] [Related]
60. Tuberous sclerosis complex 2 gene product interacts with human SMAD proteins. A molecular link of two tumor suppressor pathways. Birchenall-Roberts MC; Fu T; Bang OS; Dambach M; Resau JH; Sadowski CL; Bertolette DC; Lee HJ; Kim SJ; Ruscetti FW J Biol Chem; 2004 Jun; 279(24):25605-13. PubMed ID: 15066998 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]